Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2025-12-24 @ 11:51 PM
NCT ID:
NCT02293551
Brief Summary:
The purposes of this study are to determine:
* Part A
* How quickly your body absorbs, breaks down and gets rid of the different formulations of insulin lispro compared to insulin lispro alone formulation.
* The safety of insulin lispro in different formulations and any side effects that might be associated with it.
* Part B:
* How much insulin lispro from different dose ranges is found in the bloodstream using a test insulin lispro formulation (selected from Part A).
* The safety of insulin lispro in different formulations and any side effects that might be associated with it.
Participants may only enroll in one part. The study is expected to last up to 10 weeks for each part.
Study:
NCT02293551
Study Brief:
Protocol Section:
NCT02293551